tDCS and Spasticity in Stroke Patients
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Sep 12, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called transcranial direct current stimulation (tDCS) to see how it affects spasticity, motor recovery, and quality of life in stroke patients. Spasticity is when muscles become stiff or tight, making movement difficult. The researchers want to understand how tDCS works for people with different levels of stroke severity, ranging from mild to severe, according to a standard measurement scale.
To participate in this study, you need to have had a stroke for more than six months and experience some level of spasticity. Both men and women can join, and they will be looking for participants with varying degrees of stroke severity. Unfortunately, if you have any metallic implants or other neurological disorders that could affect your ability to follow instructions, you may not be eligible. If you decide to take part, you can expect to follow a standardized treatment plan and help improve our understanding of how tDCS can benefit stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke for more than 6 months.
- • Both genders.
- • Spasticity score ≥1 at modified ashworth scale.
- • National Institutes of Health Stroke Scale (NIHSS) for severity level; Mild (1-4), Moderate (5-15), Moderate to Severe (16-20), Severe (21-42)
- Exclusion Criteria:
- • Have any metallic implant including intracranial electrode, pacemaker, surgical clip.
- • Any symptoms effecting understanding of instructions.
- • Any neurological disorder
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Mirza Obaid Baig, MSPT
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported